Zinger Key Points
- Private equity firm Thoma Bravo is reportedly exploring a sale of Instructure Holdings.
- Thoma Bravo owns 83% of the education software provider.
Instructure Holdings Inc INST shares are moving higher Monday following reports suggesting Thoma Bravo is exploring a sale of the education technology company.
What Happened: On Friday, Reuters reported that private equity firm Thoma Bravo is exploring a sale of Instructure Holdings. Thoma Bravo owns 83% of the education software provider.
Instructure Holdings shares jumped in early trading Monday and have continued to trend higher. Instructure Holdings had a market cap of $2.96 billion as of Friday’s close, per Benzinga Pro.
People familiar with the matter reportedly said Thoma Bravo has tapped JP Morgan Chase & Co JPM to get a feel for the level of interest of potential buyers, including buyout firms.
Instructure provides software to schools, colleges and universities, featuring its flagship learning management system Canvas. The Salt Lake City-based company has over 8,000 customers in more than 100 countries.
Thoma Bravo took Instructure private in 2020 for $2 billion. The private equity firm then returned Instructure to public markets a year later via an initial public offering at $20 per share. Instructure shares have traded relatively flat since that time, underperforming the S&P 500 by a wide margin.
Instructure reported financial results for the first quarter near the beginning of the month. The company delivered revenue growth of 20.7% on a year-over-year basis, but missed earnings estimates for the quarter. As of March 31, Instructure had $89.3 million in cash and cash equivalents and $1.173 billion in debt.
Check This Out: Roaring Kitty Phones Home? GameStop Influencer Goes Silent After ‘E.T.’ Movie Clip Signals Potential Goodbye
INST Price Action: Instructure shares were up 8.78% at $22.05 at the time of publication, according to Benzinga Pro.
Photo: courtesy of Instructure Holdings.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.